Pfizer Inc. (PFE.DE) XETRA
21.85
-0.13(-0.59%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
21.85
-0.13(-0.59%)
Currency In EUR
| Market Cap | 141.98B |
| Enterprise Value | 210.55B |
| P/E Ratio | 19.44 |
| PEG Ratio | -3.38 |
| Price/Sales Ratio | 2.3 |
| Price/Book Ratio | 1.62 |
| Enterprise/Revenue | 3.29 |
| Enterprise/EBITDA | 12.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.12 |
| Operating Margin | 0.23 |
| Return On Assets | 0.04 |
| Return On Equity | 0.08 |
| Revenue | 62.58B |
| Revenue/Share | 11.13 |
| Gross Profit | 46.52B |
| EBITDA | 10.19B |
| Net Income | 7.77B |
| Diluted EPS | 1.36 |
| Total Cash | 13.03B |
| Total Cash/Share | 2.3 |
| Total Debt | 64.21B |
| Total Debt/Equity | 0.72 |
| Current Ratio | 1.25 |
| Book Value Per Share | 15.89 |
| 52-Week Change | 6.51 |
| 52-Week High | 24.92 |
| 52-Week Low | 20 |
| Moving Average 50 Days | 22.9 |
| Moving Average 200 Days | 22.15 |
| Average Volume | 43,150 |
| Shares Outstanding | 5.7B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1.72 |
| Trailing Annual Dividend Yield | 6.72 |
| Payout Ratio | 1.31 |
| Last Split Factor | N/A |
| Last Split Date | N/A |